Having trouble viewing this email? View the online version.
ISSM logo

Latest News from the ISSM - December 30, 2016 Member Login
Happy New Year!

All of us at the ISSM would like to wish you and your families a very happy, healthy, and prosperous new year!

- Prof. Luca Incrocci, ISSM President, and the ISSM Board of Directors



Low Incidence of Blood Clots Found in U.S. Transgender Women on Hormone Therapy

Venous thromboembolism (VTE) - blood clots - are uncommon in transgender women undergoing cross-sex hormone therapy in the United States, researchers have found. 

The study, recently published in the Journal of Sexual Medicine, focused specifically on hormone preparations used in the U.S., which are different from those used in Europe.  

VTE has been a concern for individuals transitioning from male to female. Clots may form in the legs or break off and travel to the lungs. Much of the research on VTEs in this population has concentrated on the European protocols. 

For this study, scientists examined the medical charts of 676 transgender women undergoing cross-sex hormone therapy in the U.S. between 2008 and 2016. The participants were on therapy for an average of 1.9 years. 

Only one patient experienced a VTE during this period, resulting in a rate of 0.15%. 

Future studies that compare the U.S. and European approaches directly are needed to determine which combinations are the safest and most effective, the authors said. 

Click here for more details. 

You are receiving this newsletter because you are subscribed to our mailing list.
If you would rather not receive emails like this in the future you can unsubscribe.

ISSM | International Society for Sexual Medicine
P.O. Box 94 | 1520 AB Wormerveer | The Netherlands